Valneva reports first-half loss, reaffirms 2026 revenue guidance

Seeking Alpha··FR·Read original
2▲0 ▼1Impact / 5
Summary · why it matters

Valneva reported a first-half 2026 GAAP loss of €0.35 per share on revenue of €65.84 million, down 32.5% year over year, and reaffirmed its full-year guidance. The company expects 2026 product sales of €135 million to €150 million and total revenues of €145 million to €160 million, with product gross margins improving in the second half after one-off effects in the first half. Valneva also said it implemented a global restructuring to reduce cash burn through workforce reductions, reprioritized R&D, and streamlined operations, and agreed to sell its Nantes site in France for €6.2 million, with the transaction expected to close in September 2026. The company held a solid cash position of €121.5 million as of the end of June 2026.

Impact on assets 1

Health Care▼ · 1 stocks
Valneva SE
VLA
▼ NegativeCapitalrelevance

First-half loss and 32.5% revenue decline, though guidance reaffirmed and restructuring may help.